Literature DB >> 17894922

Comorbidity of fibromyalgia and psychiatric disorders.

Dan Buskila1, Hagit Cohen.   

Abstract

There are mounting data supporting comorbidity of fibromyalgia syndrome (FMS) and psychiatric conditions. These include depression, panic disorders, anxiety, and post-traumatic stress disorder (PTSD). The nature of the relationship between depression and FMS is not fully understood, and it was hypothesized that chronic pain causes depression, or vice versa, and that chronic pain syndromes are variants of depression. A link between PTSD symptoms and FMS has been reported, and both conditions share similar symptomatology and pathogenetic mechanisms. Assessment of comorbid psychiatric disorders in FMS patients has clinical implications because treatment in these patients should focus both on physical and emotional dimensions of dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17894922     DOI: 10.1007/s11916-007-0214-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  55 in total

1.  Posttraumatic stress disorder, tenderness and fibromyalgia.

Authors:  M Amir; Z Kaplan; L Neumann; R Sharabani; N Shani; D Buskila
Journal:  J Psychosom Res       Date:  1997-06       Impact factor: 3.006

2.  Frequency of mastalgia among women veterans. Association with psychiatric conditions and unexplained pain syndromes.

Authors:  Kay M Johnson; Katharine A Bradley; Kristen Bush; Carolyn Gardella; Dorcas J Dobie; Mary B Laya
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

3.  The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort.

Authors:  Thorsten Giesecke; Richard H Gracely; David A Williams; Michael E Geisser; Frank W Petzke; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2005-05

4.  PTSD and physical comorbidity among women receiving Medicaid: results from service-use data.

Authors:  Julia S Seng; M Kathleen Clark; Ann Marie McCarthy; David L Ronis
Journal:  J Trauma Stress       Date:  2006-02

5.  The impact of life events in female patients with fibromyalgia and in female healthy controls.

Authors:  U M Anderberg; I Marteinsdottir; T Theorell; L von Knorring
Journal:  Eur Psychiatry       Date:  2000-08       Impact factor: 5.361

Review 6.  How do we know that the pain in fibromyalgia is "real"?

Authors:  Richard E Harris; Daniel J Clauw
Journal:  Curr Pain Headache Rep       Date:  2006-12

7.  Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis.

Authors:  G A McCain; K S Tilbe
Journal:  J Rheumatol Suppl       Date:  1989-11

8.  Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors.

Authors:  Thorsten Giesecke; David A Williams; Richard E Harris; Thomas R Cupps; Xiaoming Tian; Thomas X Tian; Richard H Gracely; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2003-10

Review 9.  Current status of cortisol findings in post-traumatic stress disorder.

Authors:  Rachel Yehuda
Journal:  Psychiatr Clin North Am       Date:  2002-06

10.  Health status, somatization, and severity of posttraumatic stress disorder in Vietnam combat veterans with posttraumatic stress disorder.

Authors:  J C Beckham; S D Moore; M E Feldman; M A Hertzberg; A C Kirby; J A Fairbank
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

View more
  19 in total

1.  Sleep disturbance in Moroccan patients with ankylosing spondylitis: prevalence and relationships with disease-specific variables, psychological status and quality of life.

Authors:  Jinane Hakkou; Samira Rostom; Mariam Mengat; Nawal Aissaoui; Rachid Bahiri; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2012-03-24       Impact factor: 2.631

Review 2.  [Expert testimony in post-traumatic stress disorder with pain as the main symptom].

Authors:  U T Egle; U Frommberger; B Kappis
Journal:  Schmerz       Date:  2014-08       Impact factor: 1.107

3.  Psychiatric disorders in Ehlers-Danlos syndrome are frequent, diverse and strongly associated with pain.

Authors:  Samantha Aliza Hershenfeld; Syed Wasim; Vanda McNiven; Manasi Parikh; Paula Majewski; Hanna Faghfoury; Joyce So
Journal:  Rheumatol Int       Date:  2015-10-03       Impact factor: 2.631

4.  CORR Insights®: Complex Regional Pain Syndrome After Distal Radius Fracture Is Uncommon and Is Often Associated With Fibromyalgia.

Authors:  Michael J Moskal
Journal:  Clin Orthop Relat Res       Date:  2018-04       Impact factor: 4.176

5.  A cross-sectional survey assessing sources of movement-related fear among people with fibromyalgia syndrome.

Authors:  Leslie Russek; Sarah Gardner; Kelly Maguire; Caitlin Stevens; Erica Z Brown; Veroni Jayawardana; Sumona Mondal
Journal:  Clin Rheumatol       Date:  2014-01-31       Impact factor: 2.980

6.  Depression, abuse and its relationship to interstitial cystitis.

Authors:  H B Goldstein; P Safaeian; K Garrod; P S Finamore; S Kellogg-Spadt; K E Whitmore
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-09-03

7.  Nociceptive and anxiety-like behavior in reproductively competent and reproductively senescent middle-aged rats.

Authors:  Alicia A Walf; Jason J Paris; Cheryl A Frye
Journal:  Gend Med       Date:  2009

8.  Preliminary investigation of absent nociceptive flexion reflex responses among more symptomatic women with fibromyalgia syndrome.

Authors:  Masataka Umeda; Lisa W Corbin; Katrina S Maluf
Journal:  Rheumatol Int       Date:  2013-04-04       Impact factor: 2.631

9.  The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study.

Authors:  Yvonne C Lee; Lori B Chibnik; Bing Lu; Ajay D Wasan; Robert R Edwards; Anne H Fossel; Simon M Helfgott; Daniel H Solomon; Daniel J Clauw; Elizabeth W Karlson
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

Review 10.  Developments in the scientific and clinical understanding of fibromyalgia.

Authors:  Dan Buskila
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.